Perhaps, in the future, the epigenetic modification of PPARγ may be intervened to regulate the expression of genes involved in lipogenesis without compromising metabolism in vivo, thereby reducing the occurrence of obesity and obesity-related diseases (Figure 5). This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.